Xue H - Search Results

1

Angiotensin II enhances beta-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats.

Schutzer WE, Xue H, Reed JF, Roullet JB, Anderson S, Mader SL. Schutzer WE, et al. Among authors: xue h. Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2807-14. doi: 10.1152/ajpheart.2000.279.6.H2807. Am J Physiol Heart Circ Physiol. 2000. PMID: 11087235 Free article.

2

Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteins.

Schutzer WE, Xue H, Reed JF, Mader SL. Schutzer WE, et al. Among authors: xue h. J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):899-906. doi: 10.1093/gerona/61.9.899. J Gerontol A Biol Sci Med Sci. 2006. PMID: 16960020

3

Schutzer WE, Xue H, Reed J, Oyama T, Beard DR, Anderson S, Mader SL. Schutzer WE, et al. Among authors: xue h. Vascul Pharmacol. 2011 Nov-Dec;55(5-6):178-88. doi: 10.1016/j.vph.2011.09.001. Epub 2011 Sep 17. Vascul Pharmacol. 2011. PMID: 21951806

4

Mevalonate availability and cardiovascular functions.

Roullet JB, Xue H, Pappu AS, Roullet C, Holcomb S, McCarron DA. Roullet JB, et al. Among authors: xue h. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11728-32. doi: 10.1073/pnas.90.24.11728. Proc Natl Acad Sci U S A. 1993. PMID: 8265617 Free PMC article.

5

Farnesyl analogues inhibit vasoconstriction in animal and human arteries.

Roullet JB, Xue H, Chapman J, McDougal P, Roullet CM, McCarron DA. Roullet JB, et al. Among authors: xue h. J Clin Invest. 1996 May 15;97(10):2384-90. doi: 10.1172/JCI118682. J Clin Invest. 1996. PMID: 8636420 Free PMC article.

6

Effects of FK506 in rat and human resistance arteries.

De Lima JJ, Xue H, Coburn L, Andoh TF, McCarron DA, Bennett WM, Roullet JB. De Lima JJ, et al. Among authors: xue h. Kidney Int. 1999 Apr;55(4):1518-27. doi: 10.1046/j.1523-1755.1999.00366.x. Kidney Int. 1999. PMID: 10201018 Free article.

7

Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.

Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S. Komers R, et al. Among authors: xue h. Transl Res. 2007 Dec;150(6):343-9. doi: 10.1016/j.trsl.2007.07.001. Epub 2007 Aug 15. Transl Res. 2007. PMID: 18022596

8

Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Roullet JB, Xue H, McCarron DA, Holcomb S, Bennett WM. Roullet JB, et al. Among authors: xue h. J Clin Invest. 1994 May;93(5):2244-50. doi: 10.1172/JCI117222. J Clin Invest. 1994. PMID: 8182156 Free PMC article.

9

Cardiovascular consequences of immunosuppressive drug treatment: a comparative study of cyclosporine A and cyclosporine G.

Roullet JB, Xue H, Burdman EA, Chapman J, McCarron DA, Bennett WM. Roullet JB, et al. Among authors: xue h. Transplant Proc. 1995 Feb;27(1):346-7. Transplant Proc. 1995. PMID: 7879023 No abstract available.

10

Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells.

Roullet JB, Luft UC, Xue H, Chapman J, Bychkov R, Roullet CM, Luft FC, Haller H, McCarron DA. Roullet JB, et al. Among authors: xue h. J Biol Chem. 1997 Dec 19;272(51):32240-6. doi: 10.1074/jbc.272.51.32240. J Biol Chem. 1997. PMID: 9405427 Free article.

Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoconstriction (Roullet, J.-B., Xue, H., Chapman, J., McDougal, P., Roullet, C. M., and McCarron, D. A. (1996) J. Clin. ...

Earlier experiments with animal and human arteries have shown that farnesol, a natural 15-carbon (C15) isoprenoid, is an inhibitor of vasoco …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,386 results

Search Page